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Rationale: Antibiotic resistance compromises achievements of modern medicine and is a major threat 
to the society. The oral cavity has the distinct microbial community that serves as a reservoir for 
determinants of antibiotic resistance. Tet(M) gene is abundant in bacteria residing in the oral cavity 
and is often identified in oral specimens. Absolute quantification of resistance genes copies allows 
quantitative studying the factors possibly associated with these numbers. Bacterial aerosol at the 
workplace may pose occupational risk. Exposure to aerosolized bacteria may contribute to increased 
resistance genes copy numbers in oral bacteria of dental personnel. 
Objective: To investigate the prevalence and levels of tet(M) resistance gene in saliva samples 
collected from two observational groups and any associated factors that might influence the levels of 
tet(M). 
Methods: Saliva samples were collected from 83 healthy dental students of Institute of clinical 
dentistry, UiT, Norway, in the period from 1 June to 27 November 2015. The study participants were 
grouped by their study year: 41 newly recruited students and 42 senior students. The latter were 
exposed to dental office environment as a part of the practice skill exercises. The quantification of 
tet(M) gene copies in DNA extracted from the saliva samples was done using droplet digital PCR 
(ddPCR) methodology. Self-administered questionnaires were distributed in order to obtain 
demographic and health-related variables. To find out whether the two observational groups had 
different number of tet(M) gene copies, Mann-Whitney-Wilcoxon test was used. Pearson's correlation 
coefficient and the linear regression analysis were used to reveal any association between antibiotic 
consumption and tet(M) gene copy numbers found in the samples. 
Results: Each saliva sample was positive for tet(M) gene (100% prevalence). The number of tet(M) 
gene copies was not significantly different between the two groups with and without exposure to 
 vii 
dental office environment. The history of antibiotic courses taken in the past was not correlated with 
tet(M) gene copy number.  
Conclusion: exposure to dental office environment does not influence significantly the tet(M) gene 
copy number in saliva samples in the study population. The number of antibiotic courses did not seem 


















AR antibiotic resistance 
ARGs antibiotic resistance genes 
CFU colony-forming unit 
CVR covariance ratio 
ddPCR droplet digital polymerase chain reaction 
DNA deoxyribonucleic acid 
DUWS from dental unit water system 
GP general practitioner 
HGT horizontal gene transfer 
HVE high-volume evacuator 
IKO Institute of Clinical Dentistry 
MIC minimum inhibitory concentration 
µL microliter 
MRSA methicillin resistant Staphylococcus aureus 
MSIS Surveillance System of Communicable Diseases 
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NorPD Norwegian prescription database 
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1.1 Antibiotic resistance - general terms 
1.1.1 Antibiotic resistance (AR) 
The threatening status of antibiotic resistance has been recognised and raised highly on the agenda 
among international health authorities. Still, the current epidemiologic figures are immense. The latest 
WHO report reveals that the prevalence of antibiotic resistance in some clinically significant bacteria 
may exceed 50% in many countries of the WHO regions (1). Recent surveys put the annual death toll 
attributed to antibiotic resistance at 23,000 lives for the US. The situation is even worse in the EU 
countries. Around 25,000 people die every year as a consequence  of untreated infections (2, 3).  
Aside from human costs, AR entails huge economic losses. The direct healthcare costs and the cost of 
productivity losses in the US are estimated at $ 20-35 billion and $ 35 billion per year, respectively (4, 
5). Yet these figures are likely to be underestimated. According to Smith and Coast, there are certain 
limitations in health economic studies of antibiotic resistance (5). The authors have estimated that a 
hip-replacement surgery without antibiotic prophylaxis might lead to two times higher probability of 
postoperative infection development. The consequent mortality was calculated to be 30% higher under 
the designed scenario (5). Such economic modelling is difficult to apply to the diversity of medical 
cases where antibiotics are involved (5). Branches of medicine such as surgery, obstetrics, and 
oncology are dependent upon the effectiveness of antibiotic treatment (5-7) and it is difficult to 
estimate the actual cost of antibiotic loss (5). Nonetheless, the current knowledge of the economic 
losses caused by antibiotic resistance should indicate how big the problem already is. 
 
Apart from the current state of bacterial resistance to antibiotics, the prospect of the post-antibiotic era 
may imply dramatic changes for society. Even though much effort has been done in tackling the issue, 
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it is widely accepted that the achievements are not enough to restrain the spread and maintenance of 
antibiotic resistance rates. In a number of publications the post-antibiotic era is regarded as nothing but 
an unavoidable reality (1, 6, 8). This literally means  our society may roll back to the times where a 
minor skin injury could lead to deadly complications. Public health bodies appeal to fight AR 
immediately (1, 2). The passive acceptance of the problem can compromise the status of modern 
medicine - inaction may become a critical mistake for the well-being of societies (1, 5, 6, 8).  
 
In essence, AR is the ability of bacteria to survive the antibiotic treatment. The property of pathogenic 
bacteria to resist antibiotic therapy became evident soon after the invention of antibiotics. An enzyme 
capable of undermining the effect of penicillin was discovered even before the introduction of the drug 
to a wide human use (6). Apart from developing adaptation to one type of antibiotic agents, bacteria 
have managed to upgrade their protective mechanism(s) so that they could survive treatment with 
several antibiotics (6). Recent findings have shown the existence of bacterial strains which are totally 
drug resistant, even to drugs of last resort (6, 9).  
 
While the "antibiotic resistance" term comprises the resistance of bacteria to antibiotics, antimicrobial 
resistance refers to the resistance of a number of microorganisms, such as bacteria, fungi, viruses, and 
parasites, to antimicrobial agents (1).  In the present work, it has been chosen to use the term 
"antibiotic resistance" given that the study deals with tet(M)-mediated bacterial resistance to 
tetracycline. Further on, all antibacterial and antimicrobial agents are referred as "antibiotics".  
 
The resistant bacterial strains pose a major concern for clinicians, patients and public health authorities 
as they become increasingly observed both in hospital and community settings. Ineffective 
antibacterial treatment due to AR demands alternative therapeutic options, frequently more expensive 
(and not readily available). Failures of a first-line treatment also lead to higher rates of mortality and 
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increase in days of stay under treatment (1). Not only have these pernicious bacterial properties 
compromised the success of infectious diseases' treatment, but the outcomes of some modern surgical 
procedures, such as organ transplantation or implantation of medical devices, have become more 
uncertain (6, 7). Anti-cancer therapy may in some cases do more harm than good if antibiotics have no 
effect (7).  
 
1.1.2 Antibiotic resistance classification. 
There are several types of antibiotic resistance described in literature. Primarily, resistance can be 
either intrinsic or acquired (6, 7, 10). In addition, some bacteria are phenotypically refractory to 
antibiotic challenge. This type of resistance, known as non-inherited,  is caused by structural and 
physiological adaptations of bacterial populations to antibiotic's action (11). This phenomenon occurs, 
for example, due to ability of bacteria to form biofilm - a bacterial community residing on solid 
surfaces of bodily tissues, implanted devices, etc. (11). The dental biofilm is an example of such 
communities (12). Biofilms may contain several bacterial species, the interaction of which results in 
altered properties allowing to withstand exposure to antibiotics (11).  
It is well accepted that the acquired resistance is primarily responsible for maintenance and expansion 
of antibiotic resistance at levels concerning public health authorities worldwide (6, 7, 10).  
Apart from the abovementioned classification, which is based on the mechanisms of antibiotic 
resistance, AR can be either clinical or/and microbiological. The clinical AR refers to the condition 
where an adequate antibiotic therapy against an infectious disease, in terms of dosage and schedule of 
administration, does not cure a patient (13). In contrast, the microbiological antibiotic resistance refers 
to the presence of mechanisms conferring the resistance in bacterial isolates tested in the laboratory 
(13). However, the detection of the resistance mechanisms among bacteria in the laboratory may or 




1.1.3 Genetic determinants of antibiotic resistance 
According to S.B. Levy, the development of antibiotic resistance principally can be expected where 
the co-occurrence of two main factors is presented: an antibiotic and the genetic prerequisites within 
the bacterial genome, namely, the antibiotic resistance genes (ARGs) (8). Interactions of these two 
elements are extensively investigated and, to date, it is widely accepted that bacteria either can acquire 
the drug resistance through transfer of genes of resistance or through mutation in the bacterial genome 
(6-8). The resistance genes do not travel alone - they are disseminated via one of the mobile genetic 
elements: plasmid, transposon, integron, naked DNA, and bacteriophages (8). All these means of 
resistance gene transmission can be united under the term of horizontal gene transfer (HGT) (10). 
Mutations and HGT are considered to be the main genetic mechanisms responsible for ARGs 
dissemination (10, 15).  
Mutation of bacterial DNA is the alteration within the bacterial genome so that new properties are 
acquired (10). The mutant bacterial strains spread the altered genetic information through the passage 
of genes to its offspring, i.e. vertical gene transfer (VGT) (16). 
Mutations to resist antibiotics can be exemplified by a study of a Mycobacterium tuberculosis strain 
where 29 mutations have been observed during prolonged treatment with use of a combination of 
antibiotics (6). The susceptible M. tuberculosis strain evolved to multidrug resistance strains in order 
to survive the treatment. Such a rapid reaction against its extinction may be explained by the presence 
of genes that have potential to be altered/mutated, proto-resistant genes (15), and selection pressure 
exposed to the bacteria by applying antibiotics (14). This kind of selection follows the same Darwinian 
principle where the fittest organisms proliferate, with an amendment, it is a human-made scenario (6). 
HGT is considered the most contributing factor to the dissemination of antibiotic resistance globally 
(10). While the vertical gene transfer is responsible for passing parental genes to offspring, HGT is a 
sophisticated mechanism of transferring genetic information that makes bacteria able to obtain genes 
within a single generation. When the resistance genes are acquired, bacteria are able to recombine 
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them in order to obtain new properties such as resistance or/and virulence (17). The passage of the 
genes is not constrained within certain genera of bacteria - it has been documented that it may occur 
between different species (12, 17). HGT and mutations, the two main mechanisms of acquired 
resistance occurrence, have evolved due to high selection pressure by contemporary antibiotics 
applications (6, 15). 
The origins of the resistant genes are not entirely understood. It has been hypothesized that ARGs 
originate either from bacteria of normal flora or from environmental bacterial populations (6, 7). The 
concept of antibiotic resistome was proposed by Davies (6) and Wright (15). The resistome is the 
collection of those genes that are responsible for conferring antibiotic resistance in bacteria (15). It is 
not surprising to know that microbial world is full of rivalries for existence. The bacterial production 
of toxic compounds to kill other bacteria was estimated to occur as early as 3.4 billion years ago (18). 
The development of resistance to bacterial toxins has occurred as a natural response in order to survive 
in the aggressive environment (15). Some unspecific bacterial defensive mechanisms such as reduction 
of concentration of toxins in the cell and prevention of toxins entering the cell existed even before 
discovery of antibiotics (6, 15).  
According to Davies, the emergence of resistance to specific toxins might be brought about by 
anthropogenic activity. The hypothesis states that ARGs development may be a co-evolutionary 
response of environmental bacteria confronting a variety of pollutants which has saturated our planet 
since the beginning of industrial era (6). Still, the origin of ARGs remains unclear (7, 10). 
 
1.1.4 Factors that promote antibiotic resistance 
A number of studies and surveillance records have reported that the overall amount of antibiotics 
consumed is positively correlated with the incidence of antibiotic resistance (8, 10, 14, 19, 20).  
According to Canton and colleagues, the results of the ecological studies found the reciprocal 
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correlation: those countries with high levels of resistance have higher levels of antibiotic consumption 
(14).  
In the ecological study by Bronzwaer et al., the resistance of Streptococcus pneumoniae to β-lactam 
antibiotics was positively correlated with consumption of the antibiotics in 11 European countries. S. 
pneumoniae was chosen as an indicator of susceptibility to penicillin because of its clinical relevance 
and evidence of increasing rates of its drug resistance. The outpatient sales of antibiotics were used as 
a representation of drug consumption (20). In the study by Mackenzie et al., the research team found a 
positive association between the total use of antibiotics in 128 European hospitals and the prevalence 
of methicillin resistant Staphylococcus aureus (MRSA) (21). In the systematic review by Bell et al., 
the authors showed the development of antibiotic resistance at both individual and community level 
was significantly associated with consumption of antibiotics. The authors included results from a 
variety of study designs such as cross-sectional, case-control, ecological, cohort, and experimental 
studies (19).  
The role of mankind in promoting antibiotic resistance is beyond doubts. It is difficult to estimate 
quantitatively amounts of drugs produced by pharmaceutical companies as disclosure of this 
information often lies outside the companies' area of concern. It is assumed that during the period from 
the discovery of antibiotics to the present day the pharmaceutical industry released immense amounts 
of these drugs at GP's disposal and for other purposes (6).  
In general, the application of antibiotics for nontherapeutic purposes is observed in aquaculture, 
veterinary, cattle and research industry (6). The use of antibiotics for growth promotion in the cattle 
industry promotes resistance at clinically important levels (8, 14). This type of antibiotic application is 
considered a factor aggravating the present state of the resistance problem and has been banned in 
Europe (8). Yet it is debatable whether compliance to this ban is universally achieved. Many 
developing countries have poor control over antibiotics usage which can be seen as an opportunity for 
pharmaceutical industry. The consequence is the distribution of low-quality drugs into markets of 
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developing countries that plays a role in dissemination of the resistance (6). In light of this, the 
resistance issue is seen as a problem that is fuelled by social inequalities. Taken together, 
anthropogenic activities are predominantly responsible for selection pressure for ARGs to be 
omnipresent in the environment (6, 10, 14, 15).  
1.2 Antibiotic resistance in Norway 
1.2.1 Status of antibiotic resistance 
Although the resistance to antibiotics in Norway is estimated as being low compared to other EU 
countries, some infectious diseases have become difficult to treat because of emerging antibiotic 
resistance bacteria (22). The prevalence of antibiotic resistance in clinical isolates from Norwegian 
hospitals vary across the types of bacterial isolates. So, the Norwegian Surveillance System of 
Communicable Diseases (MSIS) reported the raise in proportion of nonsusceptible Escherichia coli to 
fluoroquinolones from 9.1% in 2011 to 11.7% in 2013. This increase was found to be correlated with 
prescribing behaviour regarding this antibiotic (22). In 2013, MSIS detected 22% increase in total 
MRSA events compared to 2012. The resistance to gentamycin and ampicillin in a sample of 81 
clinical isolates of Enterococcus faecium was found to be 46.8% and 97.5%, respectively (22).  
To our knowledge, a number of studies have been done to examine antibacterial resistance in oral 
environment of Norwegian population. In the study by Al-Haroni et al., the samples of dental biofilm 
were collected from 21 dental patient volunteers attending two dental offices in Bergen. A comparison 
group consisted of 34 dental patients visiting dental clinics in Sana'a, Yemen. The examination of the 
Norwegian participants showed that 7.9% and 11.3% of cultivable bacterial strains collected from the 
dental biofilm were resistant to ampicillin and metronidazole, respectively. These figures were lower 
in comparison  to  those of the Yemeni observation group (23). 
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In the study by Handal et al., bacterial isolates were obtained from dental biofilm of 25 patients with 
refractory marginal periodontitis. The patients were referred from a dental clinic in Oslo after being 
examined by a specialist in periodontics. The conventional treatment of the periodontitis was not 
successful prior to enrolment to the study. The age of participants ranged from 39 to 66 years. The 
results showed that 68% of patients had bacteria resistant to β-lactam antibiotics in their dental biofilm 
(24). 
The available data on antibiotic resistance in Norway points to the effectiveness of policies aimed to 
contain the issue. Even though there are some changes in figures of antibiotic resistance, overall, the 
level the resistance is sustainable and few countries do better (22).  
1.2.2 Consumption of antibiotics 
The Norwegian prescription database (NorPD) was introduced in 2004. It has enabled to link the 
prescription of drugs, including antibiotics, sold in pharmacies to the individual personal number of 
residents of Norway (25).  This database covers the whole country population providing high-quality 
statistics at individual and population levels and thus overcoming the disadvantages attributed to self-
reported drug consumption. 
Overall antibiotic consumption in Norway is considered to be stable over years and less than in other 
European countries (26). In 2012 Norwegian total sales of systemic antibiotics tallied 17.4 defined 
daily doses (DDD) per 1000 inhabitants per day. The two most frequently prescribed antibiotics are 
penicillin and tetracycline (27). Since NORpd allows to correspond drug prescriptions with age and 
gender of patients, it was possible to evaluate differences in the prescribing pattern. In the study by 
Blix et al., it has been found that females aged 19 to 35 years consume twice as high amount of all 
systemic antibiotics than males matched by age. The consumption of tetracycline however was 
estimated to be higher in males (37% of all prescribed systemic antibiotics) in the age group of 15-34 
years than in females (23% of all prescribed systemic antibiotics). The same study showed high 
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antibiotic users were adolescent males and males older than 75 years. Interestingly, tetracycline was 
the most prescribed drug for the adolescent males (28).  
1.3 Oral cavity and antibiotic resistance 
1.3.1 Oral cavity as a reservoir for antibiotic resistance 
The oral cavity is the entrance to the gastrointestinal tract and the respiratory system. The mouth as an 
organ is responsible for some essential functions such as food chewing, swallow, speech, and 
breathing. They make the oral cavity a unique ecological niche colonized by a multitude of 
microorganisms - bacteria, viruses, fungi etc. The composition of oral bacterial inhabitants is complex 
with around 1000 distinct species (29, 30). Oral bacterial communities are dynamic and comprised of 
different species depending on the distinct features of the habitat microenvironment. For example, 
bacterial composition and diversity in dental plaque is different from that of saliva or tongue (29).  
Microbes of the normal microflora, or alternatively commensals, are generally considered as "bacterial 
strains deemed not actively responsible for a pathogenic process..."(31). Their presence is commonly 
perceived as of benefit to the human host. Gut microflora and skin microflora are the examples (31). 
An individual is estimated to accommodate 3.9 x 1023 commensals on average. This figure is much 
less for pathogens (31). According to Marshall et al., commensal organisms might represent a 
sufficient reservoir of antibiotic resistance. The authors point to the growing evidence that commensals 
are capable to transfer the resistance genes to clinically significant pathogens (31). Still, the findings 
are modest because previous works were focused mainly on studying pathogens (1, 31). As stated by 
Sommer et al., the normal human microflora might interact with bacterial pathogens at the site of 
infection. The authors emphasized the possibility of passing the genetic traits conferring resistance to 
antibiotics to initially susceptible pathogens (32). 
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It is noteworthy that oral bacteria can acquire genetic fragments conferring resistance from other 
transient bacteria (12). Therefore, oral bacteria could exchange genetic material with intestinal 
bacterial community and bacteria found in food and drinks (17).  Olsen and co-workers consider the 
oral microbial community as being a reservoir for dissemination of ARGs that enriches from the 
environmental reservoir (resistome) (17).  
A recent review has shown that ARGs found in oral cavity predominantly confer resistance to β-
lactams,  macrolides, and tetracyclines (33). However, the  authors emphasized these genes do not 
directly correspond to presence, or magnitude of antibiotic resistance in the samples. Instead it was 
suggested to consider the identified genes as a potential to confer clinically significant antibiotic 
resistance (33). 
 Nevertheless, the data on ARGs prevalence in the mouth are alarming. A report by Lancaster et al. 
discovered that prevalence of tetracycline resistance bacteria was 97,9% in in a group of 47 
presumably healthy children aged 4-6 (34). Another study of international European group of 
volunteers comprised of 21 healthy adults showed the tetracycline resistance genes were present in 
each saliva sample (35). The same study demonstrated high prevalence of erythromycin resistance 
genes. Participants from all countries were positive for the presence of erythromycin resistance gene 
except those from England (35). A study of saliva collected from 52 Japanese healthy volunteers 
illustrated the presence of resistant genes to β-lactams in all samples (36). Taken together, the 
aforementioned findings describe the high prevalence of resistant bacteria in oral cavity across several 
countries. These findings may have serious clinical implications as mentioned antibiotics are used for 
treatment of a variety of infectious disorders such as pneumonia, cholera and some sexually 
transmitted diseases (35). The possible shift from mere presence of the resistance genes to clinical 
antibiotic resistance may constitute a public health challenge. Besides public health implications, the 
presence of antibiotic resistant bacteria in oral cavity cause difficulties of dental diseases treatment 
 
 11 
(29). The oral bacteria are responsible for a number of oral disorders such as dental caries and its 
complications, periodontal pathology (29, 37). If not being effectively treated, dental diseases 
eventually lead to teeth loss, which ultimately may contribute to the loss of gastrointestinal tract 
functionality, appearance, and speech alterations.  The oral bacteria can be also found at other sites of 
human body. Although their causative role in infectious diseases is under debates, the oral pathogens 
were identified in infected myocardial tissues, acute infections of liver and brain (29). 
1.3.2 Identification of antibiotic resistance in oral cavity 
In oral microbiology, biological samples such as saliva, dental plaque, and mucosa swabs are 
conventionally examined in the laboratory to identify antibiotic resistance bacteria (33). Saliva is a 
biofluid that is easily accessible for sample collection. The process is quick, cheap and non-invasive. 
Saliva has a diagnostic value as it contains a multitude of bacterial species: those of residents or 
transient oral microflora, and commensals or pathogenic bacteria (29). However, it should be noted 
that bacterial composition of saliva is distinct in comparison to other bacterial communities residing, 
for instance, in dental biofilms. The differences are seen both in taxonomy of the bacterial 
communities and the proportions of the taxa  (29). In this respect saliva may be thought of as a 
"representative" of all bacterial communities colonizing the mouth as the biofluid bathes nearly all 
surfaces of the oral cavity.  
Among the diversity of the oral bacteria, it is estimated that only half can be cultivated (29). This 
means that some 500 bacterial species found in the mouth cannot grow under laboratory conditions 
and, thus, the investigation of resistance genes present in cultivable species from saliva is limited to 
those bacteria that are cultivable. Until recently, a few studies explored the proportion of those 
samples that exhibit clinical antibiotic resistance (34, 36, 37). The presence of clinical antibiotic 
resistance in a bacterial isolate is conventionally identified through determining the minimum 
inhibitory concentration (MIC) value for bacterial isolates found in clinical samples. The MICs are 
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commonly defined in the laboratory in order to provide information on what concentration of 
antibiotics is enough for successful treatment of a given bacterial infection in clinical settings (14). In 
spite of huge clinical importance, this approach is not able to monitor the potential of ARGs in non-
cultivable bacteria. In the light of the fact that oral bacteria can easily transfer and exchange the 
resistance genes  through HGT mechanisms (12, 17), the need in examining bacterial DNA along with 
bacterial colonies should be considered. Scientific progress allowed the use of new technologies of 
molecular detection and quantification of molecules of interests such as ARGs. The droplet digital 
PCR (ddPCR) is an example of these molecular techniques (38).  
The ddPCR detects and quantifies copy number of molecules of the gene(s) of interest with high 
precision. The unique feature of the method is that a DNA sample is partitioned up to 20,000 droplets 
prior to polymerase chain reaction. After the procedure, the droplet reader device calculates the 
amount of DNA target copies. The outcome of this measurement is presented as a number of target 
gene copies (38). The previous works that aimed to quantify absolute numbers of bacterial gene copies 
in a given biological sample used normalization of the gene quantification results (39), which is 
important for the comparison of gene copies numbers across several samples. The reason behind is that 
DNA extraction procedure yields unknown proportion of bacterial DNA in the analyzed samples. 
Normalization is also used to reduce the effect of PCR efficiency variability. The normalization 
procedure accounts for impact of DNA that comes from viruses, fungi, protozoan, and human cells. 
Conventionally, a "housekeeping" gene such as 16S ribosomal RNA (16S rRNA) gene can be chosen 
for the purpose of quantification of copy number of certain bacterial genes (40-42). Another method, 
normalization by total DNA concentration, has been described in works aimed to quantify gene copy 
numbers (43).  
Interestingly, in studies exploring distribution of the resistance genes in oral cavity the question of 
quantity of the genes was not addressed. As stated by Moraes et al., the majority of publications aimed 
 
 13 
to investigate the prevalence of clinical antibiotic resistance across samples found in the oral cavity  
(33). 
1.3.3 Factors that promote antibiotic resistance in oral cavity 
Humans encounter resistance genes as early as at the very first seconds of life - during delivery (44). 
Furthermore, the mode of delivery is known to be an important factor determining the profile of 
resistance genes in the oral bacteria. The study by Allicea-Serrano and colleagues has identified tet(M) 
and tet(O) resistance genes in oral samples collected from those babies who were delivered vaginally. 
The babies who were delivered by Caesarean section, in contrast, were positive for presence of tet(W) 
and tet(O) bacterial resistance genes (44). 
It has been suggested that antibiotic therapy for treatment of both systemic and local infectious 
diseases may lead to the selection of resistant bacterial strains and their transient elevation in the 
mouth (45, 46). However, the proportion of antibiotic resistant strains found to return to the baseline 
level after some time after start of the therapy. These findings do not explore the quantitative changes 
of the resistance genes in oral cavity. Genetic material carried by bacteria, no matter live or dead cell, 
is readily transferrable to commensals or other bacterial species (12). In theory, the interaction of oral 
bacteria and antibiotic agents cannot be averted - the stable levels of antibiotic concentrations in saliva 
during therapy with antibiotics (47), and the variety of microorganisms in the mouth create 
comfortable conditions for selection of the fittest microbes and, consequently, dissemination of 
resistance genes occurs (6). 
An alternative way to affect the variation of resistance genes in the mouth is through consumption of 
food and drinks which could contain ARGs (17). Use of antibiotics as growth promoters in food 
industry may generate a linkage between environmental reservoir of antibiotic resistance and the 
reservoir represented by human microflora (10, 32). The genes that confer resistance to antibiotics 
have been identified in commercially available food and drinking water (48, 49).  
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In addition to environmental exposures, some therapeutic practices such as former traditional use of 
amalgam fillings in dental treatment may have contributed to selection of mercury-resistant bacteria 
and promotion of antibiotic resistant oral strains (50).  
1.3.4 Antibiotic resistance as an occupational risk in dental office 
A number of studies sought to elucidate the occupational risk in dental practice with regard to 
microbial contamination. One of the mechanisms to pose a risk of pathogens transmission to medical 
personnel is through the exposure to bioaerosol that is present in the dental office environment (51, 
52). A contemporary dental unit consists of a set of handpieces including a high-speed air-rotor 
handpiece (turbine), a low-speed micro engine, an ultrasonic scaler, and an air-water handpiece, at 
least (51). The handpieces are used in the way the bioaerosol and splatter are formed. Bioaerosols are 
the suspension of particles less than 50 micrometres in diameter that can stay airborne for a long 
period of time (51). Splatter is referred to as particles larger than 50 micrometres in diameter (52). The 
substance consists of air, water/saliva, particles of dental restorations, enamel and carious tissue 
fragments. The area of splatter dispersion is estimated as up to 120 cm from the site of dental 
operation (51). 
The composition of bioaerosol is complex and may include water particles generated by use of 
handpieces and biofluids derived from the oral cavity (51-53).  
The water from dental unit water system (DUWS) has been extensively investigated as a part of the 
infection control program in dental offices. A worrisome fact is that the water from DUWS is found to 
be contaminated by microorganisms despite the adherence to guidelines for maintenance and 
disinfection of the DUWS in dental practice (53).  
In the review by Walker and Marsh, the presence of microorganisms in DUWS is explained by the 
formation of microbial biofilms on the inner surface of the tubing. The authors propose the biofilms 
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are a reservoir for pathogens and, possibly, the resistance genes associated with them. The biofilms of 
the tubing are found to be recalcitrant towards disinfection procedures. The elimination of the 
microbial aggregates is difficult even with use of effective commercial agents (53). 
On the other hand, the dental bioaerosol is constituted from the particles that derives from the oral 
fluids. The latter is an environment harboring a variety of microorganism such as bacteria, viruses, 
fungi, etc.(29, 52). A dentist equipped with the handpieces mobilizes dental debris, saliva, dental 
plaque through use of high-speed bur rotation or ultrasound vibrations (51, 52). This biological 
mixture is aerosolized and, coupled with droplets from DUWS, theoretically contaminates air and 
surfaces in the radius of up to two metres with the centre at the operating site (54).   
A number of studies aimed to measure bacterial load in the dental aerosol (55, 56). The researchers 
used culture-based methods where the samples of air in dental office were collected and cultured on a 
nutrient medium for further assessment. The bacterial quantity was estimated in colony-forming units 
(CFU) per cubic meter of space (52). This method provides a good representation of bacterial load for 
comparison of various techniques in dental practice, e.g. ultrasonic scaling versus air-rotor drilling. 
Still, there may be an underestimation of total bacterial load in the dental aerosol (52, 56). The reasons 
for that are as follows: some bacteria cannot be cultured at all, the nutrient medium favours growth of 
limited types of bacteria, and bacteria are prone to disruption of the cell due to aerosolization (56, 57).  
Despite possible limitations of methodology, Dutil and co-workers estimated concentration of bacteria 
in aerosol as much as 2.8 x 103 CFU per cubic meter (56). On a contrary, the research group of 
Bennett discovered this concentration to be 7.0 x 103 CFU per cubic meter at its peaks (55). Dutil et al. 
suggested that the possible reason for such discrepancy in numbers is due to impact of oral hygiene 
condition on the concentration of bacteria in aerosol. The volunteers in his study had no oral pathology 
and received only hygienic dental cleaning (56). These findings indicate that there is an abundance of 
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living bacteria in the dental aerosol and more bacteria may be aerosolized when treating patients with 
poor oral health state. 
 Possibly downplayed bacterial concentration figures may disguise the prevalence of the resistance 
bacteria in the dental aerosol. A recent in vitro study showed that the cellular membrane of some 
bacterial cells is damaged during aerosolization. The disruption of bacterial cell structures invokes the 
release of free bacterial DNA as a part of aerosol composition (57). The results of the study suggest 
that detection of potentially dangerous DNA in the dental aerosol is complicated. A few studies have 
been done aiming to estimate the prevalence of the resistance genes in aerosols in healthcare settings. 
The report presented by Gilbert et al. describes the presence of tetracycline and erythromycin 
resistance genes in air samples obtained from wards of a pulmonary care unit (58). A study of 
bioaerosol samples collected from air of vacant wards in a hospital showed up to 70% of the cultured 
bacteria were resistant to β-lactam antibiotics (59). Prevalence of antibacterial resistance in dental 
bioaerosol or quantification of ARGs are currently not described in literature. 
 
The small size of the particles in the bioaerosol poses a special risk onto dental team. The smallest 
particles less than 5 micrometres are able to reach bronchi and alveoli, which makes the aerosol a 
vector in infections transmission (51, 52, 56). Dental professionals use personal protective equipment 
such as gloves, gowns, goggles, visors, masks to protect themselves from the bacterial contamination 
as postulated in the guidelines (60). Regardless these precautions, the dental bioaerosol particles are 
able to go around the protection contacting with eyes, skin, oral mucosa and respiratory system (51, 
52). Additionally, the contact with the aerosol is possible even when the treatment is done. The 
bioaerosol remains persistent in dental office air for up to 30 minutes after the end of a dental 
procedure (55). This implies that dental staff must not remove the protective means when 
communicating with patient past procedure.  
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Inhalation of airborne bacteria in the dental office is a challenge for both dental team and patients. 
Patients may be exposed to aerosolized microbes from DUWS and from own oral cavity (51). A face 
mask protects dental staff from inhalation of the aerosol only if it is worn and fitted properly (56).  
Experts in the field of occupational health encourage dental team members to reduce the volume of the 
dental aerosol before it is gone from the operational site in the mouth (51, 52). A technical solution for 
it is the use of high-volume evacuator (HVE). Commonly, it is an air-sucking tube with the opening of 
8 millimetres at minimum. The device evacuates up to 30 cubic metres of air per minute from the 
operation site (52). This advantage, however, is possible only when a dentist cooperates with a dental 
assistant. This working technique is not universally implemented. The example is a dental hygienists 
who mainly work alone (52). Another way to minimize bioaerosol formation is use of rubber dam. 
This device isolates teeth from the oral environment and prevents saliva bathing the operation site. 
Even though this method is highly effective in reduction of aerosol, it cannot be applied in certain 
clinical situations of dental treatment (52). The reduction of airborne bacteria in the air of dental office 
is also achieved by use of air-ventilation systems, maintenance and cleaning of DUWS,  and 
compliance to the general infectious control recommendations (51).  
Although the combination of the protective measures minimize the risks of exposure to bioaerosol in 
dental office (51, 52), it does not mean the risk is completely eliminated  (52).  Considering the 
limitations in methodology of the bacterial load estimates in the aerosol and the scarcity of literature 
about the bacterial resistance in the dental aerosol, the occupational risk in dentistry may be not fully 
recognized yet. 
1.3.5 Tetracycline resistance 
One of the most relevant forms of resistance in dental practice is tetracycline resistance (33, 37). 
Today, tetracycline is one of the most prescribed antibiotics in Scandinavian countries (27). It is the 
second most prescribed antibiotic for systemic use in Norway (22).  
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Tetracycline is effective against infections caused by a variety of gram-positive and gram-negative 
bacteria (61). The wide usage of tetracycline as a human and animal therapeutic predetermined an 
extensive dispersion of the antibiotic in the environment (62). 
 The resistance to tetracycline in bacteria is primarily due to acquisition of new accessory genes. The 
genes are often associated with the mobile genetic elements such as plasmids and transposons (61). 
The tetracycline resistance genes, tet genes, encode proteins (I) to reduce concentration of antibacterial 
agents in the bacterial cell through activation of efflux-pumps, (II) to protect the bacterial ribosome 
from its inhibition by tetracycline, (III) to activate enzymes of tetracycline molecule 
modification/inactivation, and (IV) to induce unknown mechanism of the resistance  (61-63). More 
than 1190 tet genes have been identified and classified into 41 resistance determinant groups (63).  
The most abundant tetracycline resistance determinant in the oral environment is tet(M) (12, 35, 62, 
64). The gene encodes proteins of ribosomal protection against inhibitory properties of tetracycline 
molecules (63). The high prevalence of tet(M) in the oral cavity can be explained by its location on the 
Tn916-like mobile genetic element which, in turn, is found in many oral bacteria. This mobile genetic 
element is also capable of being spread among different oral bacterial genera (12, 17, 35). In addition, 
there is an experimental evidence that Tn916-like transposons can be exchanged between the dental 
biofilm bacterial community and other members of oral microbiome (65).  Commensals carrying tet 
genes can be virtually found in oral cavity of nearly everyone (62). Such a dramatic presence of tet 
genes may be a consequence of the huge selective pressure exerted by the introduction of tetracycline 
in 1953 (62). 
The screening of both commensal flora and oral pathogens for the presence of tet(M) should be helpful 
for understanding of the prospective of clinically significance of their presence (31) 
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1.4 Aim of the study 
It is known that bacteria and resistance genes are being exchanged between different communities, 
individuals, and bacterial populations. Despite probably good hygiene habits, dentists/dental students 
might have an increased risk of contamination because they work closely with infected people and use 
equipment that can help microbes to spread in the working environment such as handpiece. In other 
words, are the prevalence and levels of tet(M) found in saliva associated with how long the dentist / 
dental student has been working in the clinic? The hypothesis of this study is that there is an 
association between tet(M) in saliva and exposure to dental office environment.  
1.4.1 Specific objectives 
(1) To detect the tet(M) gene and quantify the number of tet(M) gene copies in the bacterial DNA 
extracted from saliva samples. 
(2) To evaluate whether the level of tet(M) gene in saliva is different between 1st- and 5th-year dental 
students.   
(3) To explore any possible association between detected tet(M) gene copy numbers and total number 
of antibiotics' courses taken previously in life accounting for possible confounders. 
1.5 Implications of findings 
Since our method is based on absolute quantification of tet(M) gene copy numbers in samples from 
healthy subjects, the results will reflect the levels of the resistance genes found in bacterial DNA at 
individual level. The study hence will use a novel approach where samples collected from participants 
are compared on the basis of absolute numbers. It is noteworthy that the number of ARGs may not 
reflect the clinical antibiotic resistance (13, 66). We aim to study the presence of antibiotic resistance 
in healthy subjects for better understanding of factors that can possibly influence it. The knowledge of 
these factors should help in getting more insights into the AR problem, especially on how often 
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healthy individuals carry ARGs and for how long they persist without any selection pressure at the 
individual level. 
The comparison of the two observational groups, one that have been exposed to dental clinical settings 
and the other that have not, will provide an insight of how the antibiotic resistance is influenced by 
dentistry as an occupation. Our results could reveal also how effective personal protection equipment 
(PPE) used in dentistry prevent transmission of ARGs in dental offices. Our study in this sense can be 
viewed as a pilot one for the assessment of possible risks in catching ARGs via aerosolized bacteria 
exposure in dental offices, and, not least,  for establishing droplet digital PCR- based method of 














2 Materials and Methods 
2.1 Study design 
This is a comparative cross-sectional study that uses both descriptive and analytic approaches. 
Demographic characteristics and information about health parameters were obtained by a structured 
questionnaire composed of 32 questions, see Appendix 1. Laboratory analysis was done to reveal the 
presence and levels of the genetic targets of interests in the saliva samples. The data collection was 
carried out from 1st of June 2015 to 27th of November 2015. The saliva samples were collected from 
participants at the Department of Clinical Dentistry (IKO), University of Tromsø. The participants 
filled in the questionnaire immediately after saliva sampling. 
2.2 Study participants 
A total of 97 dental students of the Department of Clinical Dentistry (IKO), University of Tromsø 
were invited to the study of whom 47 and 50 were from the 1st year and 5th year of study, respectively. 
The invitation letters (see Appendix 2) were sent out through the student's e-mail service provided by 
the university. The invited students were presumably healthy. 
The 1st-year students were new to the IKO and have not started to take any sessions in the dental 
clinics or treat any patient at this stage of their education. The 5th-year students were introduced to 
dental practice during the 6th semester of their study (3rd-year) studying at the IKO, and have spent 
approximately 1.5 years providing dental treatments to patients.  
The participants were recruited to the study if fulfilled the following inclusion criteria: (1) being a 
dental student either in the 1st- or 5th- year of study at IKO, (2) absence of any systemic health 
problems, (3) and no antibiotic was taken in the last 3 months prior to study. Accordingly, the 
exclusion criteria were: (1) presence of a systemic disease, (2) a continuous need for medication 
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known to alter the composition of oral bacteria, and (3) use of any antibiotic during the past 3 month. 
All participants provided both verbal and written consent to participate in the study prior to saliva 
sampling and filling in the questionnaire. The study was ethically approved by the Regional 
Committee for Medical and Health Research Ethics, North Norway (Ref.nr. 2015/1048). 
2.3 Sample collection  
The participants were informed that they should have avoided smoking the last hour before saliva 
collection session. Consumption of food and drinks were not advised one hour prior to saliva 
sampling. Those participants with orthodontic appliances were asked to keep them in the mouth during 
the procedure. In the beginning, the participants were asked to sit quietly in a dental chair for 5 
minutes to relax. Then, they were given a sterile paraffin wax to chew for approximately 30-60 
seconds. The first portion of stimulated saliva was swallowed. The saliva expectorated in the next 3 
minutes was then collected into a disposal sterile container (approximately 5 ml), coded with a unique 
identification number, and then stored at -80 Cº for further analysis at the laboratory. The unique 
identification number was used to match the laboratory results with the questionnaire data. 
2.4 Laboratory methods 
2.4.1 Saliva samples processing and DNA extraction 
Approximately 800 µL of saliva were diluted with  200 µL of phosphate buffered saline (PBS) and 
then centrifuged at 21,000 G for 5 min to pellet bacterial cells. The supernatant was discarded and the 
pellet was washed three times in 50 µL PBS. The pelleted cells were then transferred to  QIAcube 
robotic workstation (QIAGEN) for DNA extraction using QIAamp mini kit (QIAGEN). The final 
DNA sample was eluted in 50 µL of TE buffer. 
 
 23 
2.4.2 Total DNA quantification 
The concentration of total DNA was quantified using Qubit ® 3.0 fluorometer according to the 
manufacturer’s instructions (ThermoScientific). In brief, the Qubit ® 3.0 was calibrated using the 
Standard #1 and #2 supplied with the starter kit. To prepare the assay tubes, 198 µL of the Qubit 
working solution and 2 µL of a DNA sample were used. The DNA concentration from the samples 
was measured in ng/µL.  
2.4.3 Assessment of extracted DNA by agrose gel electrophoresis 
The extracted DNA from the saliva samples was evaluated by gel electrophoresis. A total of 10 µL of 
the eluted DNA was run in 1% agarose gel. Electrophoresis was performed at 95 V for 1 hour. GelRed 
stained was used to visualize DNA in the gels using ChemiDoc Touch Imaging System (Bio-Rad).  
2.4.4 Droplet Digital PCR 
The presence and copy number of tet(M) and 16S rRNA genes were measured by QX200™ Droplet 
Digital™ PCR system (Bio-Rad). The PCR reaction mix was prepared as follows: (1) 10 µL of 2X 
ddPCR super mix for probes (no dUTP), (2) 1 µL of custom target primers/probe for tet(M) labelled 
with FAM , (3) 1 µL of custom target primers/probe for 16S rRNA labelled with HEX to measure total 
bacteria (4) 7 µL nuclease-free water (5) 1 µL of suitable amount of diluted DNA template (1:500). 
The DNA extracted from Bacillus subtilis was used as a positive control for tet(M) and 16S rRNA 
genes.  
The prepared 20 µL reaction mix for the ddPCR was loaded to the DG8 Cartridge (Bio-Rad) and 
droplets were generated by QX200™ Droplet Generator (Bio-Rad). The prepared ddPCR reaction mix 
(40 µL) containing the droplets was then transferred to 96-well PCR plate (Eppendorf) for DNA 
amplification. The plate was sealed with Pierceable Foil Heat Seal (Bio-Rad) and placed into C1000 
Touch Thermo Cycler (Bio-Rad). The amplification parameters are shown in Appendix 3. The 96-well 
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PCR plate was then placed in the QX200™ Droplet Reader (Bio-Rad) for reading the positive and 
negative droplets and, accordingly, absolute quantification of the target molecules is calculated using 
QuantaSoft software (version 1.3.2.0, Bio-rad). The QuantaSoft software package was also used to 
analyse the data. The concentration of tet(M) and 16S rRNA genes, were set as number of gene copies 
per 1 µL of loaded sample. The threshold value to distinguish positive and negative droplets was set 
manually at 2200 of relative fluorescence units (RFUs) for tet(M) and at 4000 RFUs for 16S rRNA. 
The threshold was implemented universally to all samples in order to ensure comparability between 
samples.  
2.5 Variables 
2.5.1 Variables retrieved from the questionnaire  
Variables for descriptive statistics were retrieved from the questionnaire. They were:  gender, year of 
birth, year of study, general health state, oral health state,   a total of antibiotic-courses taken,   
presence of a chronic disease,  smoking status, smoking duration, snuff user status, snuff use duration, 
count of daily cigarettes/snuff portions, frequency of teeth brushing, frequency of interdental cleaning 
appliances use, hand washing after phone usage in dental clinic, hand washing after filling in 
ambulatory medical card in dental clinic, hand washing after performing X-ray examination in dental 
clinic, hand washing after each patient in dental clinic, hand washing before each patient in dental, 
propensity to minimize hand washing in dental clinic, age. 
The age was computed as follows:  
age = 2015 – year of birth 
Initially nominal variable retrieved from question 8 in the questionnaire was converted into a 
categorical variable comprised of the following categories: 0 – none, 1 – antihistamines, 2 – oral 
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contraceptives, 3 – drugs for treatment of colitis, 4 – thyroid hormones, 5 – immune-modulators, 6 – 
several drug entities.  
The participants reported a commercially available mark of drug for open-ended question 8 in the 
questionnaire, if applicable. Among these answers were following pharmaceutical names: "Levaxin", 
"Mercilon", "Microgynon","Cerazette","Loette", "Colazide", "Grazax", "Aerius", "Zyrtec", and 
"Zetirizine". In addition some of participants provided answers containing application of a therapeutic 
agent, e.g. "antihistaminer","p-piller", without their commercial names. We converted previously 
nominal variable into category variable sorting the drugs according to pharmaceutical registry (67) 
with following categories: (I) thyroid hormones, (II) drugs for colitis treatment, (III) oral 
contraceptives, (IV) immune-modulators, (V) antihistamines. 
2.5.2 Variables retrieved from laboratory work  
The variables retrieved from the laboratory work were: (1) absolute copy number of tet(M) gene  in the 
sample, which was reported as gene copy number per 1µL of the DNA used in the ddPCR mix, (2) 
absolute number of 16S rRNA gene in the sample, which was reported as gene copy number per 1µL 
of the DNA used in the ddPCR mix, (3) the concentration of DNA samples, which was reported as 
nanograms of DNA per 1 microliter of the DNA sample. The outcome variables were then calculated 
and reported as follows: (4) copy number of tet(M) gene per 1 million copies of 16S rRNA gene, (5) 
copy number of tet(M) gene per 1 nanogram of extracted DNA. The laboratory results (1) and (2) were 
adjusted for dilution of the original DNA sample. The initial DNA sample had a 500-fold dilution 
prior to ddPCR. Therefore, (1) and (2) from QuantaSoft readings were multiplied by 500 in order to 
refer to the initial DNA sample concentration. To compute the outcome variable (4) the following 
formula was used:  
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relative copy number of tet(M) gene1 =!"#$%&'(  !"#$  !"#$%&  !"  !"!(!)  !"#"  
!"#$%&'(  !"#$%&  !"  !"!  !"#$  !"#"
  × 106 
The reason for computing the new (4) variable is that the outcome represents the number of tet(M) 
gene copies normalized to 1 million copies of 16S rRNA gene. In contrast, the outcome variable (5) 
describes the copy number of tet(M) gene per 1ng of extracted DNA from the saliva samples. The 
latter could include DNA molecules  from bacteria, viruses, fungi, and human cells. 
To compute the outcome variable (5), the following formula was used: 
relative copy number of tet(M) gene2 = !"#$%&'(  !"#$  !"#$%&  !"  !"!(!)  !"#"
!"#  !"#!$#%&'%("#
 
In order to perform parametric statistical tests without violating the assumptions, the outcome 
variables (4) and (5) were undergone log10 transformation for further statistical analysis. As a result, 
two new variables were used for analysis, namely (4.1) and (5.1), denoting log10 transformed 
variables (4) and (5), respectively.  
2.5.3 The levels of measurement 
The binary variables were as follows: gender, year of study, presence of a chronic disease, smoking 
status, snuff user status, hand washing after phone usage in dental clinic, hand washing past recording 
the ambulatory medical card in dental clinic, hand washing after X-ray examination in dental clinic, 
hand washing after each patient in dental clinic, hand washing before each patient in dental,  minimize 
hand washing in dental clinic. Question number 13 was used to retrieve information whether a 
participant has a chronic disease or not. It was categorised as a binary variable because there were no 
participants who had chosen "not sure" on this question. Question number 14 was used to retrieve 
information about participants’ smoking habits and it was categorised as a binary variable because 
there were no participants who had chosen "I smoke every day" on this question. Consequently, the 
                                                
1 number of tet(M) gene per 1 million copies of 16S rRNA gene 
2 number of tet(M) gene per 1 ng of total DNA analysed 
 
 27 
binary variable was coded as "0" for non-smokers and "1" for those who had chosen occasional 
smoking.  
The categorical variables were as follows: general health state, oral health state, a total of antibiotic-
courses taken, smoking duration, snuff use duration, frequency of teeth brushing, frequency of usage 
interdental cleaning appliances.  
The continuous variables were as follows: all the laboratory variables and age. 
2.5.4 Dummy variables 
Initially categorical variable retrieved from question 10 (Q10) in the questionnaire had the following 
possible answers: 1 – never, 2 – 1-2 courses throughout life, 3 – 3-10 courses throughout life, 4 – more 
than 10 courses. Consequently, this variable was used as a set of dummies in the linear regression 
analysis with "never" as a reference group. 
Question number 11 in the questionnaire was split into four categorical variables with 4 possible 
categories: "never", " occasionally", "often", "very often". For the linear regression analysis the 
categorical variables were converted to a set of dummy variables with "never" being the reference. 
Question number 12 in the questionnaire was split into five categorical variables with 5 possible 
categories to choose. These were "the whole 2 weeks", "often", "more than 7 days", "less than 7 days", 
"seldom", "never". For the statement (A) "I felt myself sad and depressed", the direction of scale was 
inversed so that "never" had score "1", seldom - score "2" and so forth.  For the linear regression 
analysis the categorical variable were converted to a set of dummy variables with "never" as the 
reference. The statement (E) was converted to the set of dummies with "the whole two weeks" as the 
reference without change in the direction of the scale.  
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Initially categorical variable retrieved from question 15 in the questionnaire had 3 possible categories 
to choose. These were: "I do not smoke", "less than 3 years", "more than 3 years". For inclusion the 
variable to the regression model, a set of dummies was created with "I do not smoke" as the reference. 
2.5.5 Data sources/measurement 
All the variables acquired from the laboratory results and the questionnaire were comparable across 
the study group as the procedure of data collection was consistent for each participant. Even so, the 
variables obtained from questions 21-32 had missing values for the group of 1st-year students because 
the questions were irrelevant for their position. That is why statistical models with these variables 
were analyzed only for the group of 5th-year dental students. 
2.6 Statistical analysis 
A statistical software, IBM SPSS Statistics Version 22 and RStudio Version 0.99.879, were used for 
the statistical analysis and data visualization. R-packages Rcmdr, ggplot2, Hmisc, boot, and car were 
used in the statistical analysis. Histogram plots, Q-Q plots, the values of skewness and kurtosis, and 
Shapiro-Wilk test were used for the assessment of normality of distribution for the laboratory analysis 
outcome, i.e. variables (4) and (5). The assessment of normality of the outcome distribution was done 
to choose appropriate statistical tests in further analysis. 
To compare difference in copy numbers of tet(M) gene between the 1st- and the 5th-year dental 
students the Wilcoxon-Mann-Whitney test was used. It is an assumption-free test which is 
conventionally applied to compare two independent groups when data are not normally distributed (or 
violate other assumptions) (68). Computation of the effect sizes had the following R-script: 
effect_size<-function(wilcox_model, N){z<-qnorm(wilcox_model $p.value/2); 
r<-z/sqrt(N); cat(wilcox_model $data.name, "Effect size, r = ",r)} 




Prior to deciding whether the linear regression is an appropriate analytical tool to use, we performed 
correlational analysis between the level of tet(M) gene identified and consumption of antibiotics 
throughout life. If at least one of these binary variables had p-value less than 0.05 of its Pearson r 
coefficient, the set of dummies with "none" as the reference group was used in the linear regression 
analysis. The regression model was adjusted for age and gender.   The assessment of the regression 
model was performed as suggested by Field et al. (68). For the assessment of influential cases in the 
model, the following statistical methods were performed: hat values, covariance ratios, and Cook's 
distance. To evaluate applicability of the regression model above the drawn sample, assumption of 
independence, assumption of no multicollinearity, and values of variance inflation factor were 
assessed. The loss of predictive power of the model, also known as shrinkage, was estimated by using 













































3.1 Questionnaire results 
A total of 97 participants were examined for eligibility to be included in the study. Of the 97 
participants who provided informed consent to enter the study, 14 were excluded from the study 
because of previous use of antibiotics in the last 3 months prior to the study. Forty-one and forty-two 
students comprised the 1st- and the 5th-year dental student groups, respectively. The response rate was 
100%. The demographic characteristics of the participants are shown in Table 1.  
The mean age of the participants was 23.9 years (SD=3.74). The 5th-year dental students (mean age = 
26.2, SD=2.9) were significantly older than 1st-year dental students (mean age = 21.6, SD=2.9), p-
value <0.001. The proportion of those students considering own dental health as "very good" was 
significantly higher in the 5th-year students  group, 17 out of 42 participants, than in the counterpart 
group, 5 out of 41 participants (p-value<0.05). Most of the students considered their dental health as 
being of a good state, 50 out of 83 participants. Significantly more 1st-year students, 8 out of 41, 
reported that the status of their dental health "neither good nor bad, (p-value<0.05). This proportion 
was 2 out of 42 in the 5th-year students. Only one participant in the 1st-year students group evaluated 
his/her dental health as of being "not entirely good". 
The majority of respondents reported no use of any medications on a regular basis 52 out of 83. Use of 
oral contraceptives was as twice as high in the 5th-year females, 14 out of 42, compared to females in 
the 1st-year group, 6 out of 41 (p-value<0.05). While the 1st-year students have not been consuming 
any thyroid hormones, adrenomimetic, or a combination of several medicines, the consumption  of 
these drugs was reported by two, one, and three 5th-year students, respectively (p-value<0.05). Table 1 
summarizes all the answers obtained from the questionnaire regarding the two observational groups. 
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Table 1. Comparison of 1st- and 5th-year students regarding their answers to the different questions included in the 
questionnaire. 
  1st-year students, N=41 5th-year students,N=42 Total, N=83 
Gender 
females 30 (73.2%) 33 (78.6%) 63 (75.9%) 
males 11 (26.8%) 9 (21.4%) 20 (24.1%) 
Dental health  
Very good 5 (12,2%) 17 (40,5%) 22 (26,5%) 
Good 27 (65.9%) 23 (54.8%) 50 (60.2%) 
Neither good nor bad 8 (19.5%) 2 (4.8%) 10 (12%) 
Not entirely good  1 (2.4%) 0 (0%) 1 (1.2%) 
General health 
Very good 22 (53.7%) 24 (57.1%) 46 (55.4%) 
Good 17 (41.5%) 17 (40.5%) 34 (41.0%) 
Neither good nor bad 2 (4.9%) 1 (2.4%) 3 (3.6%) 
Frequency of sickness last 2 years 
Never 3 (7.3%) 5 (11.9%) 8 (9.6%) 
Seldom 22 (53.7%) 25 (59.5%) 47 (56.6%) 
Occasionally 12 (29.3%) 12 (28.6%) 24 (28.9%) 
Often 4 (9.8%) 0 (0%) 4 (4.8%) 
Satisfaction with teeth appearance 
Very satisfied 17 (41.5%) 17 (40.5%) 34 (41.0%) 
Fairly satisfied 22 (53.7%) 24 (57.1%) 46 (55.4%) 
Rather dissatisfied 2 (4.9%) 1 (2.4%) 3 (3.6 %) 
Medicines used daily 
None 31 (75.6%) 21 (50.0%) 52 (62.7%) 
Oral contraceptives 6 (14.6 %) 14 (33.3%) 20 (24.1%) 
Antihistamines 3 (7.3%) 1 (2.4%) 4 (4.8%) 
Immune-modulators 1 (2.4%) 0 (0%) 1 (1.2%) 
Thyroid hormones 0 (0%) 2 (4.8%) 2 (2.4%) 
Adrenomimetics 0 (0%) 1 (2.4%) 1 (1.2%) 
More than 1 drug 0 (0%) 3 (7.1%) 3 (3.6%) 
Total amount of antibiotic courses in 
life 
Never 10 (24.4%) 1 (2.4%) 11 (13.3%) 
1-2 courses  13 (31.7%) 20 (47.6%) 33 (39.8%) 
3-10 courses 15 (36.6%) 15 (35.7%) 30 (36.1%) 





3.2  Laboratory  results  
The presence of tet(M) gene copies in the saliva obtained from dental students was assessed by droplet 
digital PCR. The median of tet(M) gene copies per 1 million copies of bacterial 16S rRNA gene was 
6452 with interquartile range of 7486. The distribution of tet(M) gene copy numbers were positively 
skewed. The majority of participants were at the lower end of distribution. The range was from 814 to 
66,062 of tet(M) gene copies per 1 million copies of bacterial 16S rRNA genes (Figure 1).  
  
Figure 1. The distribution of tet(M) gene copies per 1 million of 16S rRNA genes among the whole study group (n=83). 
  
On the other hand, the median of tet(M) gene copy numbers per 1ng of DNA obtained from saliva 
samples was 4250 with the interquartile range of 6509. The range of counts was from 468 to 50901 
tet(M) gene copies per 1 ng of DNA. The distribution was also positively skewed with the majority of 




Figure 2. The distribution of tet(M) gene copies per 1 ng of DNA among the whole study group (n=83). 
 
3.2.1  Assessment  of  normality  of  data  distribution.  
1) Visual assessment of figure 1 and figure 2 suggested that there was a positive skewedness of the 
data. The majority of participants had low copy numbers of tet(M) gene per  1 million copies of 16S 
rRNA gene or/and per 1ng of DNA. 
2) The Q-Q plots shown in both figures 3 and 4 represent the distribution of our data scores that 




   
Figure 3 Q-Q plot. Sample Quantiles -  tet(M) gene copies per 1 million of 16S rRNA genes cumulative values. Theoretical Quantiles- 
cumulative probability of normal distribution. 
 
Figure 4. Q-Q plot. Sample Quantiles -  tet(M) gene copies per 1 ng of DNA cumulative values. Theoretical Quantiles - cumulative 
probability of normal distribution. 
 
3) Values of skewedness (2.64) and kurtosis (8.51) for the outcome variable "tet(M) gene copies per 1 
million copies of 16S rRNA gene" indicate that the data were not normally distributed. Values of 
skewedness (3.42) and kurtosis (14.48) for the outcome variable "tet(M) gene copies per 1 ng of DNA" 
indicate that the distribution of the scores were not normally distributed. 
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4) Shapiro-Wilk test was used to test the normal distribution of data of related to the variable "tet(M) 
gene copies per 1 million copies of 16S rRNA gene", and to the variable "tet(M) gene copies per 1ng of 
DNA". The two variables were significantly not normally distributed with W = 0.706 (p-value <0.001) 
and W = 0.632 (p-value <0.001), respectively. 
3.3  Comparison  between  two  groups  
The copy number of tet(M) gene per 1 million copies of 16S rRNA gene in saliva of the 1st-year  dental 
students (median = 6886.5, interquartile range (IQR) = 4967.3) did not significantly differ  from the 
correspondent number of the 5th-year dental students (median = 6237.0, IQR = 9877.9; Wilcoxon 
rank-sum test: W = 833, p-value = 0.917, r = -0.0114) (Figure 5). 
 
Figure 5. Comparison of copy number of tet(M) gene per 1 million copies of 16S rRNA gene between 1st- and 5th-year students.  The 
black bold line inside boxes is median. The grey boxes represent the middle 50% of tet(M) gene distribution. The upper and lower 
whiskers represent upper 25% and lower 25% of tet(M) gene distribution. The dots are outliers of tet(M) gene distribution. 
The copy number of tet(M) gene per 1ng of DNA obtained from saliva samples of the 1st-year dental 
students (median = 4667, IQR = 7324) did not significantly differ from the correspondent number of 
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the 5th-year dental students (median = 3987, IQR = 4883; Wilcoxon rank-sum test: W = 852.5, p-value 
= 0.942, r = -0.008) (Figure 6). 
 
Figure 6. Comparison of copy number of tet(M) gene per 1 ng of DNA between 1st- and 5th-year students. The black bold line inside 
boxes is median. The grey boxes represent the middle 50% of tet(M) gene distribution. The upper and lower whiskers represent upper 
25% and lower 25% of tet(M) gene distribution. The dots are outliers of tet(M) gene distribution. 
 
3.4  Analysis  of  correlations  and  the  multiple  linear  regression  
The consumption of 3-10 courses of antibiotics throughout life was positively correlated with the 
log10 counts of tet(M) gene  per 1 ng of DNA obtained from saliva samples, r = 0.216 (p-value <0.05).   
In contrast, none of the binary variables that describe consumption of antibiotics throughout life were 
correlated with the log10 transformed counts of tet(M) gene  per 1 million copies of 16S rRNA gene 
(p-value >0.05).  
The "antibiotic consumption" variable was included to the linear regression model with "counts of 
tet(M) gene  per 1 ng of DNA" as the response variable. The consumption of 3-10 courses of 
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antibiotics and more than 10 courses of antibiotics were significantly associated with, respectively, 
0.439 (CI95=0.155–0.723) and 0.480 (CI95=0.117-0.842) increase in log10 tet(M) gene copy numbers 
compared to those who had never taken antibiotics (see table 2). 
When adjusted for age and gender, consumption of 1-2 courses of antibiotics throughout life became 
significantly associated with 0.337 (CI95=0.029–0.646) increase in amount of log10 tet(M) gene 
copies in saliva compared to those who had never taken antibiotics. Adjusted for age and gender, 
consumption of 3-10 antibiotic courses was significantly associated with 0.501 (CI95=0.193-0.808) 
increases in log10 tet(M) genes when compared to never-takers. Adjusted for age and gender, 
consumption of more than 10 courses of antibiotics was significantly associated with 0.561 
(CI95=0.169-0.954) increases in log10 tet(M) gene copy number when compared to never-takers. The 
age and gender were not significantly associated with log10 tet(M) gene copy number (see table 2). 
The unadjusted model could explain 12.6% of variance of tet(M) gene in the study sample. If model is 
generalized above the sample studied, it could explain 9.3% of variance in tet(M) gene. The 
adjustment of the model for age and gender did not significantly improved the unadjusted model in 










Table 2. The linear regression models. The outcome variable is log10 tet(M) gene copy number. The predictors are: 
antibiotic consumption, age, and gender. Model 1 includes dummy variables of antibiotic consumption with "zero courses" 


















1 model 0.126 0.126 0.093   0.013   












   0.4797 0.1821 0.010 0.117 0.842 
2 model 0.0133 0.139 0.084   0.037   












   0.561 0.197 0.006 0.169 0.954 
age    -0.015 0.013 0.276 -0.041 0.012 









                                                
3 p-value of F change statistics more than 0.05 
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3.4.1  Diagnostics  of  the  adjusted  model  
Outliers / influential cases: the adjusted model  had two potential outliers with standardized residuals 
greater than 2. Their hat values, 0.09 and 0.11, were below the average hat value, 0.15. The covariance 
ratios (CVR) for both of the potential outliers were slightly below the lower boundary of 0.78. The 
values of CVR were 0.78 and 0.72. Taking the Cook’s distances of these two potential outliers into 
consideration, there should not be concern neither for outliers nor for influential cases. Assumption of 
independence: the assessment of the assumption of independent errors produced value 2.042 of 
Durbin-Watson statistic that indicates the assumption has been met. Assumption of no 
multicollinearity: the tolerance values were above 0.2. The values of variance inflation factor were 
sufficiently less than 10 and their average was 1.95. This points the assumption of no multicollinearity 
has been met. Residual's assumptions: the assumption of linearity and homoscedasticity has been met. 
The scatterplot of standardized residuals against standardized predicted values is shown in Appendix 
4. The predictive model adjusted for age and gender can predict 13.9% of variance in the outcome 












4.1  Summary  of  the  findings  and  interpretation  
In the current study, the presence and levels of tet(M) gene in saliva of dental students was evaluated 
by droplet digital PCR. All samples were positive for the presence of tet(M) resistance gene. This 
results support the hypothesis of Chopra and Roberts that the majority of population is most likely to 
have some oral bacteria carrying tet(M) gene (62). Our findings were in line with the results of the 
study by Seville et al., who identified tet(M) in all 20 saliva samples collected from healthy 
individuals (35). In the report presented by Lancaster et al., 15 out of 18 bacterial isolates obtained 
from the oral cavity of 4-6 years children were resistant to tetracycline (69). However, there was a 
principal difference between the abovementioned studies and our work in the method used for tet(M) 
identification. Lancaster et al. examined only those bacteria that could be cultivated. In contrast, in the 
current study, bacterial DNA was examined for the presence of tet(M) irrespective of the ability of 
bacteria to grow in lab or not.  
While mere detection of tet(M) gene in saliva of every tested student is an interesting finding, it is not 
easy to interpret data on tet(M) gene copy numbers in regards to their contribution to clinical 
resistance; the resistance gene could be present but inactive. In our study, we use 16S rRNA gene copy 
number as a representative of total bacterial counts in saliva samples. However, the 16S rRNA copy 
number per genome varies from one bacterial species to another. Therefore, the absolute counts of 
resistances genes were reported per 1 million copies of 16Sr RNA gene rather than bacterial cell 
numbers (42). 
The level of tet(M) gene copy number in saliva was not different in the dental students at the start of 
education and those dental students who had been already exposed to dental clinical practice settings. 
The difference in tet(M) levels in the saliva samples form two study groups was not statistically 
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significant.  Even if there was a statistical difference between the two groups, maybe it would have 
been difficult to interpret the results beyond just being statistically significant. To illustrate this 
further, for instance, a count of 10 copies of tet(M) gene in one sample and 100 copies in another 
sample does not imply that the latter sample is 10 times "more resistant" to tetracycline. Sandegren 
and Andersson suggested that the increased number of resistance gene copies, in general, could lead to 
increased levels of clinical antibiotic resistance (70). However, the authors point out that it is still 
difficult to correspond a resistance gene copy number to clinical antibiotic resistance. The study by 
Grohs et al., presented experimental evidences that clinical antibiotic resistance to tetracycline in 
Streptococcus pneumoniae  isolates was dependent on structural changes within identified tet(M) 
genes (71). In the current study, it was possible to quantify the copy number of tet(M) in each sample 
without their qualitative, or functional, assessment. Therefore, even if there had been no difference in 
average of tet(M) gene copies between the two groups, we would not be able to conclude that the 
levels of clinical antibiotic resistance were equal in the observational groups. 
It is still an open question how many copies of a given resistance gene are associated with clinical 
antibiotic resistance (66). It would therefore be tempting to design a study which could investigate the 
link between a resistance gene copy number detected in saliva and any observed clinical resistance 
related to that gene. 
A significant positive association between tet(M) gene copy number and number of antibiotic courses 
taken throughout life has been found when data expressed per 1 ng of DNA, but not when expressed 
per 1 million copies of 16S rRNA gene. The most commonly used method for quantitation of genes in 
samples with bacterial DNA is its normalization to bacterial 16S rRNA gene (41, 42, 49). 
Normalization to a certain amount of DNA is less commonly used but employed in the current study 
for a purely methodological interest. 
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The fact that correlation only exists when a rather uncommon normalization method is used, raises 
some questions that deserve further investigation. 
4.2  Limitations  
The sample size in the study was based on the previous works rather than on the computation using the 
effect size, the alpha- and beta-levels. However, similar studies used fewer study participants than this 
study. For example, Ready et al., found statistically significant difference in prevalence of amoxicillin-
resistant oral bacteria when studying two observational groups of children. The two groups consisted 
of 25 and 15 children who had not taken antibiotics within 3 months prior to the beginning of the study 
(45). In the study by Feres et al., 20 participants with chronic periodontitis were examined for the 
change in the prevalence of antibiotic resistance bacterial strains due to administration of either 
amoxicillin or metronidazole (72). Al-Haroni et al., collected plaque samples from two groups 
composed of 21 and 34 participants to explore the prevalence of oral bacterial resistant to ampicillin 
and metronidazole (23).  
The sampling frame for the current study was the Department of Clinical Dentistry, UiT, Tromsø. As 
we aimed to examine whether dental practice per se is associated with higher levels of resistance 
genes, the 5th-year dental students were chosen as the proxy for the graduated dentists and match this 
group with other group of students that has no dental clinical attachment at all, i.e. 1st-year student. 
The reason for choosing the abovementioned study subjects is better access to the participants and, 
most likely, a better response rate.  In fact, the latter was at its maximum, 97 from 97 invited students 
provided their consent to enter the study. However, the enrolled dental students might lack 
representativeness to generalize the results beyond the chosen sample frame. A better sample frame 
could be, for example, all dentists and GPs in Tromsø who spent several years in practice.  
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The two observational groups were different in age at statistically significant level of 0.05 (data not 
shown). The age variable was included to the regression model to ensure the results controlled for any 
possible confounder. Since there is evidence that the antibiotic selective pressure implied by their use 
is associated with increase in clinical antibiotic resistance (14, 15, 62), and Norwegian males in the 
age group 15-34 tend to receive more tetracycline than females (28), the gender variable was included 
to the regression analysis as a possible confounder. Intragroup variations in gender distribution was 
not likely to affect the comparison of the average level of tet(M) copy numbers between the two 
groups because there was no difference in gender distribution between the two groups (Table 1). The 
results of the linear regression showed age and gender were not confounders in our study. We 
accounted for possible interactions among the predictor variables but no significant interactions were 
identified (data not shown). 
The copy number of tet(M) in saliva was determined for both the 1st- and the 5th- year dental students. 
Since all participants in principle shared the same campus, there was a theoretical possibility of 
transferring bacterial DNA between those groups. From this perspective the two groups may not be 
considered entirely unrelated. A better group for comparison would be 5th-year students of a non-
dental faculty, preferably from another university.  
It is well-known that AR is associated with antibiotic consumption (19). In the questionnaire, the 
question number 10 "How many times in life have you been subjected to an antibiotic treatment 
course?" was used as a proxy explanatory variable for prediction of variation in the level of antibiotic 
resistance genes in saliva of the dental students. It is unlikely that most of the participants could be 
aware of all the occasions of antibacterial treatment back to their early years of life. Although the 
study findings detected association between antibiotic consumption and the level of the tet(M) gene in 
saliva, the magnitude of the effect might be measured with imprecision. Moreover, recall bias was 
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possible to be introduced to the study: the participants with lower overall health state or presence of a 
chronic disease may remember better the number of antibiotic course administered to them.   
According to Roberts and Kreth, the transient bacteria can transfer accessory genes to oral bacteria via 
HGT (12). Taking this into consideration, it would be worthwhile to identify what transient bacteria 
can be found in the study participants. In a previous study to examine bacteria isolated from poultry 
and salmon, the presence of clinically relevant tetracycline resistance bacteria was reported which 
raises questions about their carry over into the food chain (73, 74). The mode of delivery is shown also 
to be a factor that influence the profile of antibiotic resistance detected in new-borns’ oral microflora. 
While those babies delivered vaginally are positive for tet(M) and tet(O) genes in their oral bacteria, 
those delivered by Caesarean-section are positive for presence of tet(O) and tet(W) genes in their oral 
bacteria (44). Hence, the information as diverse as the dietary pattern and mode of delivery may be 
relevant for future studies. 
In the study by Ready et al., it has been suggested that amalgam restorations could be associated with 
the emergence of mercury-resistant bacterial found in the oral cavity. Furthermore, the authors stressed 
that the possibility of co-selection of tetracycline resistance genes along with mercury-resistance genes 
was biologically plausible (50). Although the amalgam in dental fillings was banned in 2008 in 
Norway, it would have been helpful to obtain information about the presence of amalgam tooth 
restorations in the oral cavity of participants. 
The questionnaire could invoke underreporting bias by asking questions regarding health-related 
behaviour such as smoking or snuff use. The possible underreporting could stem from the 
acknowledgement that smoking and snuff use are considered socially undesirable behaviours. The 
incentive of underreporting may be well enhanced by awareness that medical students should promote 




It is well known that antibiotics exert selective pressure on bacterial population (14, 15, 62). 
Furthermore, a number of experimental studies provided evidence that the volume of antibiotics was 
one of the most important factors for the development of resistance and resistance levels maintenance 
(75, 76). In the present work we studied participants that were, in general, of good health. They might 
be different from other “ordinary” students  or not-students in terms of socioeconomic status, health, 
intelligence, or health-related behaviour. The majority of the participants reported consumption of 
antibiotics of less than 10 antibiotic courses throughout life (Table 1). We thus believe that our results 
of tet(M) quantitation may not be applicable to those individuals with  systemic diseases treated 
regularly with antibiotics or to those individuals whose antibiotic consumption is substantially higher 
than in our study population.  
Overall consumption of antibiotics in Norway is lower than in other European countries (26) However, 
antibiotic consumption in Norway is similar to other Scandinavian countries (27). This suggests that 
our findings may be applicable to Scandinavian countries but not to other European countries.  
The study reported by Blix and co-workers demonstrated that consumption of antibiotics was 
associated with age of antibiotic receivers (28). Since the mean age of the participants of the present 
study was 24 years it may not be possible to generalize our findings to both more and less aged 
populations. 
Our initial aim was to examine exposure to dental office environment as an occupational risk in view 
of antibiotic resistance. The "exposure" of the students to dental practice was limited to 1,5 years. It 
may be the case that this period of time was insufficient to observe the association with the change in 
resistance genes if the effect exists. Neither this period of time dedicated to dental practice is 
comparable to those of more experienced graduated dentists. In addition, the results may not be 
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applicable to other professionals in the field. For instance, dental hygienists rarely works with 









































This work was an attempt to gain more knowledge of the problem of antibiotic resistance through 
examining the prevalence and levels of tet(M) resistance gene in two observational groups. This is the 
first study in Norway that investigated the presence and levels of tet(M) in saliva samples. In the 
current study, the levels of tet(M) gene were not significantly different between the 1st-year students 
and the 5th-year students. Therefore, we could not conclude that working in a dental clinic can be 
considered a risk factor for getting more antibiotic resistance genes.  However, it seems that the use of 
saliva as a biological sample accompanied by the highly sensitive method of ddPCR could be used as a 
diagnostic tool to reveal the presence and levels of resistance genes in a given individual. It seems also 
that the high prevalence (100%) of tet(M) reflects the use of tetracycline in the population where this 
drug is one of the mostly prescribed antibiotics nationally. It is still an open question what is the 
threshold level of a particular resistance gene in the saliva that would predict a failure in antibiotic 
treatment. As we know the presence of resistant genes could threaten the effectiveness of antibiotic 
therapy. Therefore, it would be interesting to design a future study to link failure of empirical 
antibiotic therapy to the levels of antibiotic resistance genes that could be detected in the saliva. 
 In conclusion, this study suggests that there is no evidence that support any claim that acquisition of 
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1  Kvinne 
2  Mann 
 
 





3. Hvilket studieår/arbeidsfunksjon er du i? 
1  1. studieår (odontologi) 
2  5. studieår (odontologi) 
3  Klinisk veileder (studentklinikken, IKO) 
 
 
4. Hvordan er din generelle helsetilstand nå? 
1  Svært god 
2  God 
3  Verken god eller dårlig 
4  Ikke helt god 
5  Dårlig 
 
 
5. De siste to årene – har du ofte vært syk? 
1  Aldri syk 
2  En sjelden gang 
3  En gang i mellom 
4  Ofte syk 
5  Flere ganger alvorlig syk  
 
 
6. Hvordan er din tannhelse nå? 
1  Svært god 
2  God 
3  Verken god eller dårlig 
4  Ikke helt god 
5  Dårlig 
 
7. Er du fornøyd med utseende til tennene dine? 
1  Svært fornøyd  
2  Noen lunde fornøyd 
3  Temmelig misfornøyd 
4  Svært misfornøyd 
 
 
8. Bruker du medikamenter/medisiner daglig? 









9. Har du tatt antibiotika i løpet av de siste 3 
månedene? 
1  Ja 
2  Nei 
3  Usikker 
 
 
10. Hvor mange ganger gjennom livet har du tatt en 
antibiotika-kur? 
1  Aldri 
2  1-2 ganger 
3  3-10 ganger 
4  Mer enn 10 ganger 
 
 
11. I hvilken grad er du plaget med: 
                                              (1:aldri –--------- 4:svært mye) 
                                                                (1)        (2)          (3)            (4) 
 
Føler du at du ofte er tørr i  
munnen?          
Føler du deg tørr i munnen 
når du spiser?          
Har du ofte problemer  
med kjeveleddet?          

















12. De 5 påstandene nedenfor refererer til hvordan du har følt deg i løpet av de siste 2 ukene.  
(Sett en ring ved hver påstand – rundt det tallet som passer best for deg) 
 






















































































13. Har du en kronisk sykdom som innebærer at du 
jevnlig må ha medikamentell behandling? 
(Antibiotika eller annen medisin) 
1  Ja 
2  Nei 
3  Usikker 
 
 
14. Røyker du? Om ja, hvor ofte? 
1  Røyker hver dag 
2  Røyker av og til 
3  Røyker aldri 
 
 
15. Hvor lenge har du røykt? 
1  Jeg røyker ikke 
2  Mindre enn i 3 år 
3  I 3 eller flere år 
 
 
16. Snuser du? Om ja, hvor mye? 
1  Snuser hver dag 
2  Snuser av og til 
3  Snuser aldri 
 
 
17. Hvor lenge har du snust? 
1  Jeg snuser ikke 
2  Mindre enn i 3 år 














19. Hvor ofte pusser du tennene dine? 
1  Morgen og kveld 
2  En gang per dag 
3  En gang i blant 
 
 
20. Hvor ofte bruker du tanntråd/tannstikker? 
1  Etter hver tannpuss 
2  En gang per dag 
3  En gang per uke 
4  Sjeldnere 
5  Aldri 
 
21. Hvor ofte vasker du hendene dine (i klinikken)? 
(Merk: her kan du gi flere svar) 
1  Etter telefonbruk 
2  Etter å ha skrevet journal 
3  Etter å ha tatt røntgenbilde 
4  Etter hver pasient 
5  Før hver pasient 


















22. Anser du at tannleger er under større risiko for 
smittespredning enn «folk flest»? 
1  Ja, mer enn de fleste  
2  Som «folk flest» 
3  Nei, mindre enn de fleste 
4  Vanskelig å besvare 
 
 
23. Hvem er mest utsatt for smitte på et 
tannlegekontor? 
1  Tannlegen 
2  Pasienten 
3  Tannhelsesekretæren 
4  Vanskelig å besvare 
 
 
24. Kjenner du til/har hørt om tilfeller der en 
pasient har blitt smittet etter et tannlegebesøk? 
1  Ja 
2  Nei 
 
 
25. Kjenner du til/har hørt om tilfeller der 
tannlegen har blitt smittet på tannlegekontoret? 
1  Ja 
2  Nei 
 
 
26. Tenker du at tannlegen kan beskytte seg mot 
smitte? 
1  I svært stor grad 
2  I stor grad 
3  Usikker 
4  I liten grad 
5  Overhode ikke 
 
 
27. Hva er det viktigste enkelt-tiltaket mot smitte? 
1  Unngå nærkontakt med pasient (dråpesmitte) 
2  God håndhygiene 
3  Engangsartiklene  
4  God rengjøring av utstyr 
5  Sikre rutinger for å deponere klinisk avfall 










28. På hvilken måte kan tannlegen beskytte seg når 
han/hun har en «vanlig» pasient i stolen?  
(Merk: her kan du gi flere svar) 
1  Sprite alle arbeidsflater mellom hver pasient 
2  Godt såpe-håndvask mellom hver pasient  
3  Godt håndvask med sprit mellom hver pasient  
4  Ved å bruke engangsartikler som munnbind, 
          hansker, kofferdam, plastfolie etc. 
5  Ved å avstå fra å bruke f.eks. «air-rotor»  
6  Ved å bruke spesielt egnet arbeidstøy  
7  Ved å bruke øyebeskyttelse/ visir  
8  Ved å bruke papirservietter og plast-hetter  
9  Ved å alltid bruke assistent ved stolen  
10  Ved å alltid spyle igjennom vann i treveis- 
           sprøyten og drikkevannslangen før neste 
           pasient 
11  Ved å alltid la pasienten skylle munnen i ca. 
           1 minutt med munnskyllevæske 
12  Ved å ikke berøre pasienten uten verneutstyr  
13  På annen måte 
14  Tannlegen kan ikke beskytte seg mot smitte 
15  Vanskelig å besvare 
 
 
29. Kan tannlegen eliminere smitterisiko ved å 
følge «hygieneveilederen»? 
1  Ja 
2  Nei 
3  Vanskelig å besvare 
 
 
30. Hva er viktige barrierer for god hygiene på 
tannklinikken? 
1  Glemsomhet 
2  Behandlingen tar lengre tid 
3  Ubekvemme arbeidsforhold 
4  Manglende kunnskap om smittevern 
















31. Hvilken metode ville du benyttet for å reingjøre de forskjellige redskapene?  
(Sett en ring rundt det tallet som passer best for deg) 
 













































B! Rotkanalinstrumenter! 1! 2! 3! 4! 5! 6! 7!
C! Håndstykker (bor)! 1! 2! 3! 4! 5! 6! 7!
D! Avtrykk! 1! 2! 3! 4! 5! 6! 7!
E! Undersøkelses brett! 1! 2! 3! 4! 5! 6! 7!
F! Skarpe instrumenter! 1! 2! 3! 4! 5! 6! 7!
G! Kirurgisk utstyr!
 
1! 2! 3! 4! 5! 6! 7!
 
32. I hvilke situasjoner ville du brukt de nedenfor nevnte hjelpemidlene?  
(Sett en ring rundt det tallet som passer best for deg) 
 








































B! To par hansker! 1! 2! 3! 4! 5! 6!
C! Munnbind! 1! 2! 3! 4! 5! 6!
D! Øyebeskyttelse! 1! 2! 3! 4! 5! 6!
E! Visir! 1! 2! 3! 4! 5! 6!
F! Engangsartikler! 1! 2! 3! 4! 5! 6!
G! Plast over hele stolen! 1! 2! 3! 4! 5! 6!
H! Plast også på tastatur, lampe, blyant, etc!
 





TAKK FOR DINE SVAR! 
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Bakterier og resistens-gener utveksles mellom ulike miljøer. Det er ukjent hvor hyppig resistente 
mikrober forekommer i befolkningen generelt og hvilke faktorer som bidrar til å utvikle resistens. Til 
tross for gode hygienevaner, kan tannleger/tannlegestudenter ha en økt smitterisiko fordi de arbeider 
tett på mennesker, og bruker utstyr som kan spre mikrober – for eksempel air-rotor. Hensikten med 
denne studien er å studere forekomst av antimikrobielle resistensgener, å vurdere sammenhengen 
mellom utbredelsen av disse genene og hygienevaner, og tannlegestudenters holdninger til bruk av 
smittevernutstyr. En problemstilling i studien er: Er utbredelsen av resistensgener avhengig av hvor 
lenge tannlegen/tannlegestudenten har vært i klinisk praksis? 
 
Personene som blir aksepterte til å delta i studien må ha generelt god helse og ikke ha tatt antibiotika 
de siste 3 månedene. Din medvirkning vil ta omtrent 20 min (informasjon om studien, spyttprøve og 
spørreskjema). Studien vil avsluttes juni 2016. 
 
UNDERSØKELSEN 
Vi vil samle inn spytt fra 1. års tannlegestudenter som enda ikke har behandlet pasienter og 5. års 
studenter/instruktørtannleger med klinisk erfaring. Du plasseres i et lyst rom i en stol med rett rygg. 
Du skal ikke ha spist, drukket, røykt eller hatt noe som helst i munnen den siste timen før 
undersøkelsen, og du skal ikke ha tatt andre medikamenter enn de «vanlige» kvelden før eller samme 
dag som undersøkelsen finner sted. Vi vil notere alle medikamentene som du vanligvis bruker.  
 
Du vil sitte stille i ca. 5 min. før prøven tas. I denne tiden skal du fortrinnsvis ikke snakke, men 
konsentrere deg om å roe ned kroppen. Eventuelle tannproteser beholdes i munnen. Parafinvoks 
(smakløs «kloss») tygges i 30 sek. slik at den blir myk. Spyttet svelges før testen begynner. Deretter 
må du IKKE svelge mens du samler spytt. Du skal tygge under hele testen (5 min), som om du spiser 
mat, litt på hver side. Du skal spytte regelmessig i et oppsamlingsbeger med glasstrakt. Deltakeren vil 
få sitt resultat umiddelbart. Ved verdier utenfor normalområdet, vil du bli oppmuntret til å ta 
kontakt med tannlege. 
 
Referanseverdier for stimulert helsaliva  
0,70 – 1,00 ml/minutt Lav sekresjon 
1,00 – 3,00 ml/minutt Normal sekresjon 
 
Informasjon om holdninger og kunnskap vil innhentes fra spørreskjema. Du kan når som helst trekke 




Som deltaker i studien har du rett til innsyn i alle opplysninger som blir registrert om deg, du kan 
kreve at innsamlet informasjon skal bli ødelagt eller utlevert. Alle data som samles inn vil bli gjort 
ikke-identifiserbare, dvs. at personnavn ikke fremkommer. Hver person får tildelt et 
identifikasjonsnummer og bare dette vil bli brukt ved behandling av dataene. Deltakernes navn vil 
ikke bli notert.  
Fra din spyttprøve vil vi analysere antimikrobielle resistensgener fra ditt DNA. Vi vil KUN analysere 
DNA mht antimikrobiell resistens. Vi garanterer at verken informasjon om dette eller noen annen 
informasjon fra ditt DNA vil bli spredt utenfor vår forskergruppe. Din spyttprøve og informasjonen 






Etter at studien er avsluttet vil alle innsamlede data bli ødelagt og spyttprøvene destruerte. Resultatet 
fra DNA-analysen kan du få ved å henvende deg til prosjektlederne med ditt identifikasjonsnummer. 








Konsultasjonen og undersøkelsen er uten kostnad for deltakeren. Som for all behandling av helse- og 
tannhelsepersonell i Norge er deltakerne i studien dekket av Norsk Pasientskadeerstatning (NPE).  
 
OPPFØLGNINGSBEHANDLING 
Ingen oppfølgingsbehandling er nødvendig. Dersom du likevel ikke ønsker å delta, eller bestemmer 
deg for å gå ut av studien før den er avsluttet (om ca. 1 år) er det fullt ut akseptabelt. Behandling for 
eventuell annen sykdom eller skade i munnhulen som kan bli avdekket under undersøkelsen, vil måtte 
utføres hos egen tannlege og betales av deltakeren. Resultatene fra studien vi bli publiserte i nasjonale 
og internasjonale tidsskrifter. Deltakerne kan henvende seg til en av prosjektlederne for informasjon.  
 
INNSAMLET SPYTT 
Under analyseperioden (ca. 2 mnd.) vil spyttprøven som ble tatt bli lagret på forskningslaboratoriet 
ved Institutt for klinisk odontologi, UiT. Det biologiske materialet kan bare brukes etter godkjenning 
fra REK. Alle innsamlede prøver vil bli destruerte etter at studien er avsluttet. 
 
KONFIDENSIALITET 
Alle opplysninger behandles konfidensielt og ingen vil kunne gjenkjennes i publikasjoner. Ved 
prosjektets slutt vil alle forskningsdata bli destruerte. 
 
SPØRSMÅL 
Det er frivillig å delta! Ta gjerne kontakt med oss dersom du lurer på noe. 
 
PROSJEKTLEDERE 
Førsteamanuensis Mohammed Al-Haroni, IKO – UiT tlf. 776 49151 
mohammed.al-haroni@uit.no  
Professor Tordis A Trovik, ISM - UiT tlf. 776 44297 
tordis.a.trovik@uit.no  







Jeg har mottatt skriftlig og muntlig informasjon om studien, og sier meg villig til å delta. 
 
DELTAKER: 
___________________ ____________ ____________________________ 
sted dato navn 
 
TANNLEGE: Jeg bekrefter å ha gitt informasjon om studien 
 
___________________ ____________ ____________________________ 
sted dato navn 
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Appendix 3. PCR conditions. 
Phase temp time cycle 
Preheating and enzyme activation 95 °C 10min 1 
Denaturation 95 °C 30 sec - 
Annealing and extension 58 °C 60 sec 40 
Enzyme deactivation 98 °C 10 min 1 
Store 4 °C infinite  - 

















Appendix 4. Assessment of residuals of the adjusted regression model. Top: plot of standardized 
residuals against predicted values. Middle: histogram of residuals distribution. Bottom: P-P plot of 
expected cumulative probability of normal distribution against observed cumulative probability of 
distribution. 
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